|
|
|
|
|
|
|
|
|
|
|
05.08.26 - 14:33
|
Strategy Aktie: Bitcoin-Prognose deutlich reduziert - Neues Kursziel 155 USD (Aktiencheck)
|
|
|
Arlington, VA (www.aktiencheck.de) - Strategy-Aktienanalyse von B. Riley Securities:
Die Analysten von B. Riley senken das Kursziel für die Aktie von Strategy Inc. (ISIN: US5949724083, WKN: 722713, Ticker-Symbol: MIGA, NASDAQ-Symbol: MSTR) von 215 USD auf 155 USD und bestätigen das Rating "buy".
Das Researchhaus habe seine Bitcoin-Preisannahme von 81.500 USD auf 65.000 USD reduziert. [mehr]...
|
|
|
|
|
|
|
20.07.26 - 16:18
|
Rubico Announces Termination of $30 Million Equity Line of Credit (GlobeNewswire EN)
|
|
|
ATHENS, Greece, July 20, 2026 (GLOBE NEWSWIRE) -- Rubico Inc. (Nasdaq: RUBI) (the “Company” or “Rubico”), a global provider of shipping transportation services specializing in the ownership of vessels, announced today that it has terminated the common stock purchase agreement entered into with B. Riley Principal Capital II, LLC on July 21, 2025, pursuant to which the Company had the right to sell from time to time up to $30,000,000 of its common shares. To date and prior to the termination of the agreement, the Company has sold approximately $27.1 million of its common shares pursuant to the agreement. ...
|
|
|
|
|
|
|
13.07.26 - 13:33
|
Cognition Therapeutics Participating in Fireside Chat at B. Riley Securities′ Mind, Muscle & Vision Summit (GlobeNewswire EN)
|
|
|
PURCHASE, N.Y., July 13, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, announced that the Company's president and CEO, Lisa Ricciardi, has been invited to participate in a fireside discussion at the B. Riley Mind, Muscle & Vision Summit on July 16, 2026. During the discussion with analyst, William Wood, Ph.D., Ms. Ricciardi will review the status of the Company's ongoing START study as well as the planned initiation of a Phase 3 registrational study of zervimesine (CT1812) in dementia with Lewy bodies (DLB) psychosis....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
06.07.26 - 14:33
|
Neuronetics to Participate in a Panel Discussion at B. Riley Securities′ Mind, Muscle & Vision Summit on July 16, 2026 (GlobeNewswire EN)
|
|
|
MALVERN, Pa., July 06, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that management will participate at the B. Riley Securities' Mind, Muscle & Vision Summit, an invitation-only institutional investor event being held in-person at the InterContinental Boston.Neuronetics will participate in a panel discussion titled "Commercializing the Next Wave of Novel Neuropsychiatric Drugs," alongside Compass Pathways, scheduled for Thursday, July 16, 2026. Management will also be available for one-on-one meetings with institutional investors throughout the day.This is an in-person, invitation-only event, and there will be no live webcast of the panel discussion.About NeuroneticsNeuronetics, Inc. is a leader in interventional mental health, combining innovative treatment technologies with direct pa...
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
